SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-011719
Filing Date
2022-05-02
Accepted
2022-05-02 08:15:26
Documents
13
Period of Report
2022-04-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 47683
2 ex10-1.htm EX-10.1 188717
  Complete submission text file 0001493152-22-011719.txt   451587

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE xtnt-20220427.xsd EX-101.SCH 3045
4 XBRL LABEL FILE xtnt-20220427_lab.xml EX-101.LAB 35156
5 XBRL PRESENTATION FILE xtnt-20220427_pre.xml EX-101.PRE 23037
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3666
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34951 | Film No.: 22879503
SIC: 2836 Biological Products, (No Diagnostic Substances)